Drug Shortage Report for LOVENOX WITH PRESERVATIVE 300MG/3ML

Last updated on 2024-08-08 History
Report ID 229574
Drug Identification Number 02236564
Brand name LOVENOX WITH PRESERVATIVE 300MG/3ML
Common or Proper name Lovenox 300 mg/3 mL vials
Company Name SANOFI-AVENTIS CANADA INC
Market Status MARKETED
Active Ingredient(s) ENOXAPARIN SODIUM
Strength(s) 100MG
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS INTRAVENOUS SUBCUTANEOUS INTRAVENOUS
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 1 vial
ATC code B01AB
ATC description ANTITHROMBOTIC AGENTS
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2024-06-03
Estimated end date 2024-08-09
Actual end date 2024-08-07
Shortage status Resolved
Updated date 2024-08-08
Company comments Supply delay: The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. HCPs are invited to communicate with their preferred distributor to obtain the product availability date. Patients should validate the availability of the product with their respective pharmacy. . Supply is available to market. Allocations are for protective measures.
Health Canada comments
Tier 3 Status No
Company contact information email: [email protected] Telephone: 1-800-265-7927

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2024-08-08 English Compare
v11 2024-08-07 French Compare
v10 2024-08-07 English Compare
v9 2024-08-06 French Compare
v8 2024-08-06 English Compare
v7 2024-07-17 French Compare
v6 2024-07-17 English Compare
v5 2024-06-04 English Compare
v4 2024-06-03 French Compare
v3 2024-06-03 English Compare
v2 2024-06-03 French Compare
v1 2024-06-03 English Compare

Showing 1 to 12 of 12